Dabeinong fell 5.38% Net profit fell sharply in the first three quarters

Dabeinong has changed, as of 10:39 today, the stock price fell by 5.38%, 168 million shares were traded, the transaction amount was 1.389 billion yuan, the turnover rate was 5.28%, and the latest performance forecast released by the company showed that it is expected to achieve a net profit of 100 million yuan to 120 million yuan in the first three quarters, and the net profit fell by 91.91% -93.26% year-on-year.

Reasons for the change in performance: The main reason for the decline in net profit attributable to shareholders of listed companies in the first three quarters of 2021 compared with the same period of the previous year is: During the reporting period, due to the impact of changes in the domestic pig market, pig prices fell sharply, which had an impact on the company's pig performance.

Securities Times • data treasure statistics show that among the companies that announced the first three quarters of the performance forecast today, as of press time, the stock prices are relatively strong, such as Jingu Shares, Xinlong Health, Zhezhong Shares, etc., the stock prices rose by 10.02%, 10.00%, 9.99% respectively, and the stock prices fell by 10.00%, 9.97%, and 9.96% respectively.

On the capital side, the main funds of Dabeinong in the past 5 days have generally shown a net inflow, with a cumulative net inflow of 126 million yuan, of which the net inflow of the main funds in the previous trading day was 132 million yuan, and the net outflow of the tail was 5.4104 million yuan.

According to margin data, the balance of the stock's latest (October 14) two financing is 1.814 billion yuan, of which the financing balance is 1.727 billion yuan, and the total financing balance in the past 5 days has decreased by 38.0231 million yuan, a decrease of 2.15%. (Data Treasure)

Note: This article is a news report, does not constitute investment advice, the stock market is risky, investment needs to be cautious.

Financial report analysis, intelligent monitoring

Performance forecasts, changes, limits, stops, sharp increases, and sharp increases in performance